These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31090460)

  • 1.
    Briand F; Sulpice T; Giammarinaro P; Roux X
    Benef Microbes; 2019 May; 10(5):555-567. PubMed ID: 31090460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hypercholesterolemic effect of Saccharomyces boulardii in the hamster.
    Girard P; Pansart Y; Verleye M
    Pharmacology; 2014; 94(5-6):239-44. PubMed ID: 25427779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.
    Cárdenas PA; Garcés D; Prado-Vivar B; Flores N; Fornasini M; Cohen H; Salvador I; Cargua O; Baldeón ME
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1365-1372. PubMed ID: 32125555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of
    Czerucka D; Rampal P
    World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
    Moré MI
    MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic strains improve high-fat diet-induced hypercholesterolemia through modulating gut microbiota in ways different from atorvastatin.
    Sudun ; Liu S; Xiao C; Peng C; Liang L; He X; Zhao S; Zhang G
    Food Funct; 2019 Sep; 10(9):6098-6109. PubMed ID: 31495848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
    Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
    PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.
    Moré MI; Swidsinski A
    Clin Exp Gastroenterol; 2015; 8():237-55. PubMed ID: 26316791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
    J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Probiotic Saccharomyces boulardii on Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study.
    Ryan JJ; Hanes DA; Schafer MB; Mikolai J; Zwickey H
    J Altern Complement Med; 2015 May; 21(5):288-93. PubMed ID: 25893960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
    PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.
    Yu L; Zhao XK; Cheng ML; Yang GZ; Wang B; Liu HJ; Hu YX; Zhu LL; Zhang S; Xiao ZW; Liu YM; Zhang BF; Mu M
    Sci Rep; 2017 May; 7(1):1359. PubMed ID: 28465509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccharomyces boulardii (CNCM I-745) alleviates collagen-induced arthritis by partially maintaining intestinal mucosal integrity through TLR2/MYD88/NF-κB pathway inhibition.
    Ahmad ; Zhang C; Wang Y; Ullah H; Rahman AU; Wei J; Qin YH; Wang G; Wang B; Li X
    Int Immunopharmacol; 2024 Sep; 139():112738. PubMed ID: 39053232
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lin Y; He C; Liu J; Chung HY; Chen ZY; Wong WT
    Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408257
    [No Abstract]   [Full Text] [Related]  

  • 16. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.
    Everard A; Matamoros S; Geurts L; Delzenne NM; Cani PD
    mBio; 2014 Jun; 5(3):e01011-14. PubMed ID: 24917595
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Duysburgh C; Van den Abbeele P; Morera M; Marzorati M
    Benef Microbes; 2021 Aug; 12(4):59-73. PubMed ID: 34190033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
    Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
    Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
    Waitzberg D; Guarner F; Hojsak I; Ianiro G; Polk DB; Sokol H
    Adv Ther; 2024 Mar; 41(3):901-914. PubMed ID: 38286962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharomyces boulardii alleviates allergic asthma by restoring gut microbiota and metabolic homeostasis via up-regulation of METTL3 in an m6A-dependent manner.
    Liu D; Hu L; Yang Y; Wang Y; Li Y; Su J; Wang G; Gong S
    Immunol Lett; 2024 Jun; 267():106853. PubMed ID: 38513836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.